Concepedia

Patrick Bhola

PB

Statistics

Publications

13

Citations

1K

H-Index

13

Active since

2007

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Rockefeller University

Broad Institute

Patrick Bhola is an author at Dana-Farber Cancer Institute specializing in apoptosis, oncology, and molecular oncology.

ORCID

Publications per year

2007–2021

13

Publications

13

Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis

David Lagares, Alba Santos, Paula Grasberger et al. · Science Translational Medicine · 2017 · 232 citations · Full text

, , +17

Developmental Regulation of Mitochondrial Apoptosis by c-Myc Governs Age- and Tissue-Specific Sensitivity to Cancer Therapeutics

Kristopher A. Sarosiek, Cameron Fraser, Nathiya Muthalagu et al. · Cancer Cell · 2016 · 230 citations · Full text

, , +17

MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia

Fiona C. Brown, Eric Still, Richard P. Koche et al. · Cancer Discovery · 2018 · 83 citations · Full text

, , +17

High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors

Patrick Bhola, Eman Y. Ahmed, Jennifer L. Guerriero et al. · Science Signaling · 2020 · 69 citations · Full text

, , +14

Sensitivity Analysis of Intracellular Signaling Pathway Kinetics Predicts Targets for Stem Cell Fate Control

Alborz Mahdavi, Ryan E. Davey, Patrick Bhola et al. · PLoS Computational Biology · 2007 · 64 citations · Full text

, , +17

1–5 of 13